Filing Flows

Filing Flows › Recursion Pharmaceuticals (RXRX) › Who owns the stock

Who owns Recursion Pharmaceuticals (RXRX) stock

320 funds reported Recursion Pharmaceuticals (RXRX) shares in their latest 13F filings, worth $1.5B in all. The largest holder is Vanguard Group ($193M). Last quarter 160 funds added to their stakes and 123 cut them.

Largest holders of RXRX (13F)Largest holders of RXRX (13F)Vanguard Group$193MBlackRock$185MARK Investment Management LLC$152MState Street$127MVanguard Portfolio Management LLC$114MBaillie Gifford$86.2MVanguard Capital Management LLC$83.6MKinnevik AB (publ)$65.6MGeode Capital Management, LLC$50.7MSoftbank Group$50.0M

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Group47,187,759$193Mincrease2025-12-31
BlackRock50,304,691$185Mincrease2026-06-30
ARK Investment Management LLC41,337,632$152Mincrease2026-06-30
State Street34,706,130$127Mincrease2026-06-30
Vanguard Portfolio Management LLC31,131,599$114Mincrease2026-06-30
Baillie Gifford23,487,907$86.2Mdecrease2026-06-30
Vanguard Capital Management LLC22,765,940$83.6Mincrease2026-06-30
Kinnevik AB (publ)13,434,171$65.6Munchanged2025-09-30
Geode Capital Management, LLC13,819,135$50.7Mincrease2026-06-30
Softbank Group13,636,515$50.0Munchanged2026-06-30
MIC Capital Management UK LLP9,644,033$35.4Mincrease2026-06-30
UBS Group AG8,947,102$32.8Mincrease2026-06-30
Data Collective IV GP, LLC5,941,120$21.8Munchanged2026-06-30
Nikko Asset Management Americas5,511,687$20.2Mincrease2026-06-30
Sumitomo Mitsui Trust Group5,511,687$20.2Mincrease2026-06-30

Recursion Pharmaceuticals' latest quarter

Recursion Pharmaceuticals, Q3 2026: revenue $18.6M (+258% year over year), operating margin -663.9%, net loss $119M, operating cash flow −$77.4M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most RXRX stock?

By the latest 13F filings: Vanguard Group ($193M); BlackRock ($185M); ARK Investment Management LLC ($152M); State Street ($127M); Vanguard Portfolio Management LLC ($114M).

What is the short interest in RXRX?

161,926,247 shares were sold short at the 2026-10-15 settlement, 2.52% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.